PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Ebos Group's PE Ratio without NRI is 23.31. Ebos Group's 5-Year EBITDA growth rate is 12.50%. Therefore, Ebos Group's PEG Ratio for today is 1.86.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Ebos Group's PEG Ratio or its related term are showing as below:
NZSE:EBO'
s PEG Ratio Range Over the Past 10 Years
Min: 1.01 Med: 2.12 Max: 7.03
Current: 1.86
During the past 13 years, Ebos Group's highest PEG Ratio was 7.03. The lowest was 1.01. And the median was 2.12.
NZSE:EBO's PEG Ratio is ranked worse than 57.78% of 45
companies
in the Medical Distribution industry
Industry Median: 1.11
vs NZSE:EBO: 1.86
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Ebos Group PEG Ratio Historical Data
The historical data trend for Ebos Group's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Ebos Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group's PEG Ratio Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Ebos Group's PEG Ratio falls into.
Ebos Group PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Ebos Group (NZSE:EBO) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Ebos Group PEG Ratio Related Terms
Thank you for viewing the detailed overview of Ebos Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NZSE:EBO has been successfully added to your 